The global levofloxacin market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2022-2028). A major element driving market expansion is hospital-acquired infection (HAI). Pneumonia, bloodstream infection, surgical site infection, and urinary tract infection are among the most frequent hospital-acquired infections. Government regulations to prevent and control hospital infections, the need for disinfectants and disposable safety goods to reduce the danger of infectious microorganisms will increase. For instance, in 2018, the Centers for Disease Control and Prevention (CDC) estimates that roughly 2 million people in the US are infected with hospital-acquired diseases each year. The growth of the levofloxacin market is also driven by an increase in the global geriatric population, as well as an increase in the prevalence of chronic and infectious diseases. Lack of physical activity, unsanitary conditions, and lifestyle changes will all contribute to an increase in disease burden. As the immune system is less active in the elderly, they are more susceptible to infectious infections. As the prevalence of diseases rises, so will the demand for various bacterial and infection drugs, driving up the demand for levofloxacin products. Additionally, market is expected to increase as the prevalence of kidney infections rises, biotechnology and pharmaceutical companies engage more in R&D, and the demand for better treatment methods grows. Furthermore, favorable reimbursement policies, greater use, and considerable expenditures in the development of new technologies for disease treatment are expected to drive levofloxacin market growth throughout the forecast period.
Browse the full report description of “Global Levofloxacin Market Size, Share & Trends Analysis Report by Type (250MG, 500MG, and 750 MG), and by Application (Pneumonia, Skin Infection, Kidney Infection and Bladder Infection) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/levofloxacin-market
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape- including Aden Healthcare, Allenge India Pharma, Alna Biotech Pvt. Ltd., Bestochem, DivineSavior.in and others.
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected regions and segment
Global LevofloxacinMarket Report Segment
By Infection Type
By Distribution Channel
Global Levofloxacin Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World